Cyclofenil

CAS No. 2624-43-3

Cyclofenil( —— )

Catalog No. M21643 CAS No. 2624-43-3

Cyclofenil is an estrogen antagonist has anti-dengue-virus activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 55 Get Quote
5MG 77 Get Quote
10MG 117 Get Quote
25MG 209 Get Quote
50MG 314 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cyclofenil
  • Note
    Research use only, not for human use.
  • Brief Description
    Cyclofenil is an estrogen antagonist has anti-dengue-virus activity.
  • Description
    Cyclofenil is an estrogen antagonist has anti-dengue-virus activity.(In Vitro):Cyclofenil shows an inhibitory effect on dengue virus (DENV) replication in mammalian cells but not in mosquito cells.Cyclofenil also inhibits the replication of Zika virus. A time-of-addition assay suggested that Cyclofenil may interfere with two stages of the Dengue virus (DENV) life cycle: the translation-RNA synthesis and assembly-maturation stages. The level of intracellular infectious particles decreased more drastically after treatment with Cyclofenil than the viral RNA level do, indicating that the assembly-maturation stage might be the main target of Cyclofenil.
  • In Vitro
    Cyclofenil shows an inhibitory effect on dengue virus (DENV) replication in mammalian cells but not in mosquito cells. Cyclofenil also inhibits the replication of Zika virus. A time-of-addition assay suggested that Cyclofenil may interfere with two stages of the Dengue virus (DENV) life cycle: the translation-RNA synthesis and assembly-maturation stages. The level of intracellular infectious particles decreased more drastically after treatment with Cyclofenil than the viral RNA level do, indicating that the assembly-maturation stage might be the main target of Cyclofenil.
  • In Vivo
    The number of estrogen receptors α (ERα) and β (ERβ)-immunoreactive (-ir) cells is determined of each stage of the estrous cycle in intact rats. Additionally, the effects of blocking ERα and ERβ on ovulation rate on diestrus-2 or proestrus day through the microinjection of methyl-piperidino-pyrazole (MPP) or Cyclofenil in either side of preoptic-anterior hypothalamic area (POA-AHA) are evaluated. The number of ERα-ir and ERβ-ir cells in POA-AHA varied in each phase of estrous cycle. Either MPP or Cyclofenil in the right side of POA-AHA on diestrus-2 day reduced the ovulation rate, while at proestrus day it was decreased in rats treated in either side with MPP, and in those treated with Cyclofenil in the left side. MPP or Cyclofenil produced a decrease in the surge of luteinizing hormone levels (LH) and an increase in progesterone and follicle stimulating hormone (FSH).
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Estrogen Receptor/ERR
  • Recptor
    oestrogen receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2624-43-3
  • Formula Weight
    364.44
  • Molecular Formula
    C23H24O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:21 mg/mL (57.62 mM)
  • SMILES
    CC(=O)Oc1ccc(cc1)C(=C1/CCCCC1)\c1ccc(OC(C)=O)cc1
  • Chemical Name
    44'-(Cyclohexylidenemethylene)diphenol diacetate ester

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tohma D et al. An estrogen antagonist cyclofenil has anti-dengue-virus activity. Arch Virol. 2019 Jan;164(1):225-234.
molnova catalog
related products
  • CMP8

    CMP8 is a selective ligand for estrogen receptor. CMP8 binds to the mutant estrogen receptor ligand binding domain (ERLBD).

  • Enclomiphene citrate

    Enclomiphene citrate((E)-Clomifene, cis-Clomifene, RMI-16289, ICI-46476)?is a nonsteroidal selective estrogen receptor modulator (SERM) that is under development for the treatment of male hypogonadism.

  • Promestriene

    Promestriene (INN) is a synthetic estrogen and glucocorticoid used topically in a 1% cream formulation.